| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966169 | Vaccine | 2013 | 8 Pages |
Abstract
PCV13 induces a greater functional immune response than PPSV23 for the majority of serotypes covered by PCV13, suggesting that PCV13 could offer immunological advantages over PPSV23 for prevention of vaccine-type pneumococcal infection.
Keywords
LLOQPPSV23PCV13CRM197PCV7SAEGMRGMTOPAIPDadultInvasive pneumococcal diseasePneumoniaadverse eventSerious adverse eventconfidence intervalOpsonophagocytic activityLodlimit of detectionlower limit of quantitationGeometric mean titergeometric mean ratio7-valent pneumococcal conjugate vaccinePneumococcal conjugate vaccine13-Valent pneumococcal conjugate vaccinePCV
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Kathrin U. Jansen, Deepthi Jayawardene, Carmel Devlin, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmoele-Thoma,